Unilever not deterred by rejection of $68B bid for GSK's consumer unit

• GSK last summer announced plans to spin out the consumer assets, following activist investor pressure to focus more on pharma.
• Unilever, meanwhile, will soon reveal a new strategic plan that may include divestitures of some lower-margin businesses (e.g., food, where its brands include Marmite, Hellmann’s and Ben & Jerry's), moves that were enabled by last year's change from a dual nationality to U.K.-only structure.

State of play: GSK said the Unilever bid undervalues the business, which it still plans to take public later this year.

• Reuters, however, reports that GSK would listen to offers above $81 billion.